Fig. 3From: Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa studyResponses against multiple antigens. Frequency of patients responding against multiple antigens within responding patients. Percentages of positive patients are indicated for the number of recognized tumor antigens and for multiple (≥2) recognized antigens in total. The majority of immune-responding patients exhibited responses against ≥2 different tumor antigens (PSA, PSCA, PSMA and STEAP1)Back to article page